30 June 2011
Factors influencing QTc interval prolongation during kidney transplantation
Maciej ZukowskiACDEF, Jowita BiernawskaABCDEF, Katarzyna KotfisBDE, Mariusz KaczmarczykC, Romuald BohatyrewiczA, Wojciech BlaszczykB, Malgorzata Zegan-BaranskaB, Marek OstrowskiB, Miroslaw BrykczynskiA, Andrzej CiechanowiczCDAnn Transplant 2011; 16(2): 43-49 :: ID: 881864
Abstract
Background: During renal transplantation, factors causing disturbances of the repolarization process, defined by the QT interval, may lead to ventricular arrhythmias. The aim of this study was to determine a relationship between QT interval prolongation and metabolic homoeostasis, and durations of cold ischemia time (CIT) and warm ischemia time (WIT) during renal transplantation.
Material/Methods: From among 198 consecutive renal transplant patients, 68 (mean age 45±12 years) were included in a prospective observational pilot study. Prior to the procedure, arterial blood gas analysis was performed, and digital Holter ECG monitoring was applied and continued for 12 hours. Subsequent arterial blood gas analysis was performed 30 minutes after graft reperfusion.
Results: QTc changed dynamically and significantly during the perioperative period. Ventricular arrhythmias were observed only during graft reperfusion. Recordings showed that 33 out of 68 patients had ventricular extrasystoles, and non-sustained ventricular tachycardia was observed in 2 patients. No patients presented with hemodynamic instability. There was no statistical correlation between CIT or WIT and the difference (delta) between the final and initial values of the pH, potassium and lactate levels, QTc range, maximal QTc or QTc measured at the predefined time points.
Conclusions: The renal transplantation procedure carries a high risk of ventricular repolarization period disturbances that can lead to life-threatening tachyarrhythmias despite optimal hemodynamic or metabolic status and independent of CIT and WIT.
Keywords: holter electrocardiography, kidney clinical, QT interval, renal transplantation
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






